RE:RE:RE:RE:RE:RE:RE:RE:Question for WhalewatcherYou should check out the streetwise report on algernon today. Keep in mind that algernon pays for this report. Chris provides examples of Nasdaq up listing in xortx and Diamedica, neither worked out for investors. Xortx just uplisted- was trading at $6 early October on CSE, raised $12m at $4 (typical discount) a share early October and now trades at below $2, but is Nasdaq listed. Nasdaq price was in line with CSE pricing before collapsing after listing on Nasdaq. Thoughts on this most recent example? Lots to look forward to . . .